PAPER Roczniak-Ferguson A, Ferguson SM31527135
PAPER Zhou W, Ma D, Tan EK31526091
Los Angeles, United States
Columbia UniversityNew York, United States
National Institutes of HealthBesthesda, United States
PAPER Gantier R, Gilbert D, Dumanchin C, Campion D, Davoust D, Toma F, Frébourg T
The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta.Neurosci Lett. 2000 Apr 14;283(3):217-20. PubMed: 10754226
RESEARCH NEWS 2019-09-18 Research News A Phase 3 trial of pimavanserin was halted early when the study met its primary endpoint of delaying relapse to psychosis in people with dementia, according to a press release by its sponsor, Acadia Pharmaceuticals. Pimavanserin —a ...
COMMENT Chris Dobson transformed the field of protein misfolding and aggregation, dramatically advancing our understanding of Alzheimer's disease and related disorders. He pioneered the introduction of powerful chemical and biophysical approaches, reshaping ...
Wren TherapeuticsCambridge, United Kingdom
COMMENT I had the privilege of doing my Ph.D. in Chris Dobson's lab. Under his guidance, not only did I learn how to be a better scientist at the lab bench, but also how to conduct myself as a researcher. I am eternally grateful for his kind words and ...
PAPER Pinto WB, Silva LH, Badia BM, Yanagiura MT, Souza PV, Oliveira AS31522742
PAPER Nadeau J, Smith T, Lamontagne-Proulx J, Bourque M, Al Sweidi S, Jayasinghe D, Ritchie S, Di Paolo T, Soulet D31525350
PAPER Sjöberg L, Fratiglioni L, Lövdén M, Wang HX31522861